IFN-γ ELISpot Assay Protocol
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Icahn School of Medicine at Mount Sinai
Other organizations : Duke-NUS Medical School, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Hospital General Universitario Gregorio Marañón, Hospital Universitario Fundación Jiménez Díaz, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Salud Carlos III, Autonomous University of Madrid, Hospital La Paz Institute for Health Research, Synesis, SDN Istituto di Ricerca Diagnostica e Nucleare, Istituti di Ricovero e Cura a Carattere Scientifico
Variable analysis
- Peptides
- Negative control (DMSO)
- Positive control (phorbol 12-myristate 13-acetate and ionomycin (PMA)/ionomycin)
- Interferon-gamma (IFN-γ) production
- Enzyme-linked immunospot (ELISpot) flat-bottomed, 96-well nitrocellulose plates (MAHA S4510, Millipore)
- IFN-γ monoclonal antibody (mAb) (2 μg ml^-1, 1-D1K; MABTECH) for coating plates
- 10% human AB serum for blocking
- IFN-γ mAb (0.2 μg ml^-1, 7-B6–1-biotin; MABTECH) for detection
- Streptavidin-alkaline phosphatase (1 μg ml^-1, Roche) for detection
- Substrate (5-bromo-4-chloro-3-indolyl phosphate/NBT; Sigma-Aldrich) for spot development
- Incubation conditions (37 °C, 24 h, CO2 incubator)
- Washing steps with PBS
- phorbol 12-myristate 13-acetate and ionomycin (PMA)/ionomycin
- DMSO
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!